LABT
NASD Lakewood-Amedex Biotherapeutics Inc.$0.9326 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.9326, $0.0174 below the day’s high of $0.9500
- YTD change
- -98.92%
- vs 20-day SMA
- -48.36%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-7.72 (-89.22%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.1% away from all-time highs of $98.2000
- LABT is down 99% since the beginning of the year
- LABT is down 99% over the past 12 months
- LABT is down 55% over the past 1 month
- 3% of all LABT investors are betting against LABT
LABT reads poor: the 12-month move is -89.2%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0001
- Last 5 days
- -48.90%
- vs 8-day SMA
- -33.92%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Lakewood-Amedex Biotherapeutics, Inc. engages in the development of novel antimicrobial therapies. Its anti-infective products targeted certain viral diseases like avian influenza, Epstein Barr Virus (EBV), and hepatitis B and C. The company was founded by Roderic Dale on July 11, 2006 and is headquartered in Bradenton, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.